Search over 3,000 reports

    Kynamro- Drug Insights, 2017

    Kynamro- Drug Insights, 2017
    Date: Dec, 2017
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0016
    DelveInsight's pharmaceuticals report, " Kynamro Drug Insights, 2017" highlights the Drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Kynamro covering the historical global sales and also provides the Kynamro sales estimation during the forecasted period (2017-2019). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Kynamro and emerging therapies in this space.

    Scope

    A review of the Kynamro, based on information derived from company and industry-specific sources
    Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
    Coverage of the Drug Master Files and API Manufacturers by country
    Patent Expiry Timeline and Exclusivity Details
    Route of Synthesis of the API
    Forecasted Sales Figure from 2017-2019
    Market competition and emerging therapies
    SWOT Analysis
    DelveInsight Report Introduction
    Kynamro- Overview
    Product Description
    Route of Synthesis
    Mechanism of Action
    Pharmacology
    Pharmacodynamics
    Pharmacokinetics
    Adverse Reactions
    Regulatory Milestones by Region
    Deals and Partnerships
    Product Details
    Kynamro Sales Assessment
    Historical Sales
    Forecasted Sales
    Patent Details by Region
    Company Financials
    Market Competition
    Emerging Therapies*
    Drug 1
    Product Description
    Research and Development
    Product Development Activities
    SWOT Analysis
    Appendix
    Methodology
    Consulting Services
    About DelveInsight
    Contact Us
    Disclaimer
    Table 1: Kynamro, Description
    Table 2: Kynamro, Product Details
    Table 3: Kynamro, Historical Sales (in million USD)
    Table 4: Kynamro, Forecasted Sales from 2017-2019 (in million USD)
    Table 5: Kynamro, Patent Details
    Table 6: Company, Overview
    Table 7: Kynamro Major Competitors Kynamro
    Table 8: Emerging Therapies
    Figure 1: Kynamro, Historical Sales (in million USD)
    Figure 2: Kynamro, Forecasted Sales from 2017-2019 (in million USD)
    Kynamro
    Genzyme
    low density lipoprotein-cholesterol
    LDL-C
    apolipoprotein B
    apo B
    total cholesterol
    TC





    and non-high density lipoprotein cholesterol


    non-HDL-C



    in homozygous familial hypercholesterolemia


    HoFH



    patients
    Kynamro Marketed Drugs Overview
    Kynamro Market Assessment
    Kynamro API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
    Kynamro US DMF
    Kynamro US Drug Master Files
    Kynamro Active Substance Master File/ EUDMF
    Kynamro Generic players
    Kynamro Patent Expiration
    Kynamro Patent Exclusivity
    Kynamro API Manufacturers
    Kynamro Global Forecasted Sales Figure
    Kynamro API Route of Synthesis
    Kynamro Market sales
    Kynamro SWOT Analysis
    Kynamro Pipeline
    • Single User License
      (20% Off)
      $1,000.00
    • Site License
      (30% Off)
      $2,000.00
    • Global License
      (40% Off)
      $3,000.00

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap